Skip to content

CAMBERLIN PERFUSION

Active
Private limited companyfounded 2021active for 5 yearsRuelle Benjamin(BO) 8, 7110 La Louvière, BelgiumKBO/BCE: BE 0773.572.921
Summary

The computed 12-month bankruptcy probability of CAMBERLIN PERFUSION is 2.4% (moderate). The 2025 annual accounts show equity of €6,895 and a net result of €86,037. Equity has been shrinking by about 15% per year since 2021. The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Official details

Source: KBO
Status
Active since 06-09-2021 Normal situation
Activity
No activity registered in the KBO
Establishment unit
2.321.488.330 7100 La Louvière, since 10-09-2021
Financial year end
31 December
Peppol
Reachable since 08-03-2026

Financial position

53 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
2.4%
Annual accounts 2025
Gross margin
€118,135
▲ 1.4%
Turnover
≈ €300,000
estimated
Profit
€86,037
▼ 4.1%
Equity
€6,895
▲ 17.7%
Total assets
€24,814
▼ 56.2%
Score breakdownraises riskNo main activity registeredFounded in 2021lowers riskSize: total assets €24,814Figures for financial year 2025 (filed on 28-07-2026)Show the evidence

Checked score

Score 2025
53 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially stronger than 54% of micro companies without a NACE code
Financial strength · tick: 2024
Strong
Solvency 53+18
equity 27.8% of total assets
Liquidity 36-14
short-term debt 72.2% · cash 19.6%
Profitability 100=
return on assets 346.7%
Bankruptcy probability within 12 months
2.4% Moderate
0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024lowest value 02-2025: 0.2%▲ +0.1 percentage points vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 1.3%▲ +1.1 percentage points vs 06-2025 08-2025: 2.3%▲ +1.0 percentage point vs 07-2025 09-2025: 2.3%● unchanged vs 08-2025 10-2025: 2.3%● unchanged vs 09-2025 11-2025: 2.3%● unchanged vs 10-2025 12-2025: 2.3%● unchanged vs 11-2025 01-2026: 2.3%● unchanged vs 12-2025 02-2026: 2.3%● unchanged vs 01-2026 03-2026: 2.4%▲ +0.1 percentage points vs 02-2026 04-2026: 2.8%▲ +0.4 percentage points vs 03-2026 05-2026: 3.4%▲ +0.6 percentage points vs 04-2026 06-2026: 3.8%▲ +0.4 percentage points vs 05-2026highest value 07-2026: 3.7%▼ -0.1 percentage points vs 06-2026 08-2026: 2.5%▼ -1.2 percentage points vs 07-2026 09-2026: 2.4%▼ -0.1 percentage points vs 08-2026 10-2026: 2.4%● unchanged vs 09-2026 11-2026: 2.4%● unchanged vs 10-2026
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 32% of them on solvency, 20% on liquidity, 90% on profitability and 75% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · No main activity registered
KBO
lowers risk · Size: total assets €24,814
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Founded in 2021
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Figures for financial year 2025 (filed on 28-07-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-07-2026, 3 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
3 days early
2024
50 days early
2023
9 days late
2022
39 days early
2021
32 days early
← before the deadline after the deadline →
tick = median of all Belgian filings

The company filed its last 5 accounts on average 23 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 June (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 5 profitable years in a rowprofit 2025: €86,037 5 years View

Recent changes

  1. · Gazette deed Company renamed from Rue des Marronniers, 13-7100 La Louvière to Ruelle Benjamin, 8-7110 Boussoit
  2. · Gazette deed Incorporation
All 11 events

Key facts about CAMBERLIN PERFUSION

What is the company number of CAMBERLIN PERFUSION?
The company number of CAMBERLIN PERFUSION is 0773.572.921. The VAT number is the same number with BE in front: BE 0773.572.921.
Where is CAMBERLIN PERFUSION based?
The registered office is at Ruelle Benjamin(BO) 8, 7110 La Louvière.Company details
What is the legal form of CAMBERLIN PERFUSION?
The legal form of CAMBERLIN PERFUSION is Private limited company (BV).
When was CAMBERLIN PERFUSION founded?
CAMBERLIN PERFUSION was founded on 06-09-2021.
Is CAMBERLIN PERFUSION still active?
Yes, CAMBERLIN PERFUSION is an active enterprise in the KBO register.
What is the turnover of CAMBERLIN PERFUSION?
The turnover in financial year 2025 is ≈ €300,000. This figure is estimated from the gross margin of €118,135 and 2,211 comparable companies of the same size. It probably lies between €200,000 and €460,000. It is a rough estimate.Financials
Is CAMBERLIN PERFUSION profitable?
In financial year 2025, CAMBERLIN PERFUSION made a profit of €86,037.
Where can I find the annual accounts of CAMBERLIN PERFUSION?
CAMBERLIN PERFUSION filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of CAMBERLIN PERFUSION due?
CAMBERLIN PERFUSION must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.